Exact Sciences Corporation (EXAS) Stock Analysis & Investment Frameworks
Exact Sciences Corporation (EXAS) stock analysis on Invetso. Review Exact Sciences Corporation’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Exact Sciences Corporation Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
Exact Sciences Corporation Key Financial Metrics
- Market Cap: $20.03B
- Revenue: $3.25B
- ROE: -4.34%
- ROIC: -2.11%
- Dividend Yield: N/A
About Exact Sciences Corporation
Exact Sciences Corporation specializes in developing and distributing cancer screening and diagnostic tools across the United States and internationally. Their key product, Cologuard, is an innovative, non-invasive test that analyzes stool-based DNA to identify specific DNA and hemoglobin biomarkers indicative of colorectal cancer and precancerous conditions. The company's extensive portfolio also includes the Oncotype DX family of gene expression tests, designed for breast, prostate, and colon cancers. Within this suite, the Oncotype Test provides detailed tumor profiling from tissue samples, assisting in treatment selection for individuals battling advanced, metastatic, refractory, or recurrent cancers. Furthermore, they offer the Oncotype DX AR-V7 Nucleus Detect Test, a liquid biopsy designed for advanced-stage prostate cancer patients, and Oncomap ExTra, which delivers a comprehensive biological insight into challenging, rare, or aggressive malignancies. Exact Sciences also provides COVID-19 testing services. Future initiatives involve enhancing Cologuard's performance characteristics and pioneering novel blood- and other fluid-based diagnostic tests. The company maintains important license agreements with the MAYO Foundation for Medical Education and Research and Hologic, Inc. Established in 1995, Exact Sciences Corporation's corporate headquarters are located in Madison, Wisconsin.
Exact Sciences Corporation Investment Frameworks
Invetso analyzes Exact Sciences Corporation (EXAS) across the following frameworks:
- Exact Sciences Corporation 10Y Growth Potential
- Exact Sciences Corporation Scenario Analysis
- Exact Sciences Corporation Risks & Opportunities
- Exact Sciences Corporation Economic Moat
- Exact Sciences Corporation Business Model
- Exact Sciences Corporation Management
- Exact Sciences Corporation SWOT Analysis
- Exact Sciences Corporation Porter's 5 Forces
- Exact Sciences Corporation PESTLE Analysis
- Exact Sciences Corporation ESG Analysis